Manufacturing AUTOMATION

COVID-19 Updates News Factory
ATS Automation scales up global medical device production for COVID-19 crisis


ATS Automation Tooling Systems is using its capabilities in life sciences manufacturing to expedite the production of medical equipment such as ventilators and respirators to address the COVID-19 healthcare crisis around the world.

“Organizations needing to overcome capacity constraints and supply chain shortages are turning to ATS to scale up production of critical medical devices and quickly pivot manufacturing output,” says Andrew Hider, CEO of the Cambridge, Ontario–based company, in a statement.

“A severe disruption in supply chains combined with an ever-growing demand for critical medical devices has left manufacturers looking for creative yet trusted solutions to meet demand,” says Hider.

North America

ATS Automation operates 23 manufacturing sites globally, and more than 50 engineering and service sites.

Advertisment

The company is doing contract manufacturing for medical devices at its facilities in Cambridge and Chicago.

ATS brings experience in life sciences, pharmaceutical and medical supply to manufacturers, along with the regulatory knowledge and certifications necessary to manufacture FDA and Health Canada–registered products.

In Canada, the ATS Life Sciences team is working with O-Two Medical Technologies to assemble critical ventilator components at ATS’ facilities.

In the U.S., the ATS team is supplying ventilator production test equipment to two key ventilator manufacturers. The equipment enables the calibration and testing of ventilators before shipment to hospitals and medical facilities.

ATS is working with a large automaker in the United States to reconfigure its manufacturing facility, and has delivered equipment to enable the wide-scale production of filtering facepiece respirators (FFR) masks. Launch of the project to delivery of equipment was completed in 17 days.

Europe

In Italy, Comecer, an ATS company that designs and manufactures high-technology systems for pharmaceutical industries, is developing an automated bio-decontamination system for hospitals based on the same technology used in Comecer’s aseptic isolators.

This would allow fast decontamination of hospital rooms and equipment, and potentially enable reuse of devices such as N95 masks, which would otherwise be disposable, thereby helping to mitigate shortages.

In Germany, the ATS team is developing a solution for a manufacturer of COVID-19 test kits to help them ramp up production to meet the unprecedented demand.

At IWK in Germany, an ATS company that manufactures high-speed packaging solutions, the team has developed a rapid deployment tube-filling solution suitable for hygiene products including hand sanitizer. The machine will fill up to 70 tubes per minute.